|Articles|January 1, 2002
Early signs vital in bioterrorism
New York-Biological and chemical warfare have moved to the forefrontof America's consciousness, but many ophthalmologists do not know enoughabout the ophthalmic manifestations of these weapons to make a meaningfulcontribution to the care of victims.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
SubscribeAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
2
Opus Genetics reaches FDA alignment on phase 3 registrational design for OPGx-LCA5 gene therapy
3
NeuroOp Guru: What a big data study reveals about NAION and stroke risk
4
Port Delivery System Therapies in Retinal Vascular Diseases
5


















